InvestorsHub Logo

justdafactss

08/27/20 9:58 AM

#111606 RE: KobeF #111597

PR says "emergency use approval" was requested-

Late-stage biotech CytoDyn Inc (CYDY) has announced that it has provided its Top-line Report from its recently completed Phase 2 trial of leronlimab for COVID-19 patients with mild-to-moderate symptoms to the U.S. Food and Drug Administration (FDA), and requested emergency use approval.
https://finance.yahoo.com/news/cytodyn-requests-covid-19-emergency-125739300.html

NOWHERE does is say Emergency Use Authorization (EUA) was applied for.